Exacerbation of myasthenia gravis after amoxicillin therapy: a case series

被引:6
作者
Vacchiano, Veria [1 ]
Solli, Piergiorgio [2 ]
Bartolomei, Ilaria [3 ]
Lai, Giulia [4 ]
Liguori, Rocco [1 ,5 ]
Salvi, Fabrizio [3 ]
机构
[1] Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy
[2] Maggiore Teaching Hosp, Dept Thorac Surg, Bologna, Italy
[3] IRCCS Ist Sci Neurol Bologna, Neurol Unit, Bologna, Italy
[4] Univ Hosp Chieti, Dept Gen & Thorac Surg, Chieti, Italy
[5] IRCCS Ist Sci Neurol Bologna, UOC Clin Neurol, Bologna, Italy
关键词
Myasthenia gravis; Drugs; Penicillin; Amoxicillin;
D O I
10.1007/s10072-020-04387-5
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction Myasthenia gravis (MG) can be aggravated by several classes of drugs, including antibiotics. Penicillins are considered safe drugs for the management of infectious disease in patients with MG. However, a few cases of MG exacerbations after penicillin treatment have been reported in literature. Case reports We report six patients with MG developing acute worsening of symptoms after amoxicillin or amoxicillin/clavulanate treatment. In most of the cases, symptoms started in a few days after antibiotic administration. In all cases, we observed a worsening of the Myasthenia Gravis Foundation of America (MGFA) clinical classification. Most patients required a therapeutic intervention with dosage increase of the previous therapy or the introduction of new drugs for MG. All patients had a full recovery to baseline neurological conditions within 1-2 months. Conclusions We concluded that patients receiving amoxicillin should be closely monitored for possible acute relapse.
引用
收藏
页码:2255 / 2257
页数:3
相关论文
共 9 条
  • [1] AMPICILLIN MAY AGGRAVATE CLINICAL AND EXPERIMENTAL MYASTHENIA-GRAVIS
    ARGOV, Z
    BRENNER, T
    ABRAMSKY, O
    [J]. ARCHIVES OF NEUROLOGY, 1986, 43 (03) : 255 - 256
  • [2] Barrons RW, 1997, PHARMACOTHERAPY, V17, P1220
  • [3] Italian recommendations for the diagnosis and treatment of myasthenia gravis
    Evoli, Amelia
    Antonini, Giovanni
    Antozzi, Carlo
    DiMuzio, Antonio
    Habetswallner, Francesco
    Iani, Cesare
    Inghilleri, Maurizio
    Liguori, Rocco
    Mantegazza, Renato
    Massa, Roberto
    Pegoraro, Elena
    Ricciardi, Roberta
    Rodolico, Carmelo
    [J]. NEUROLOGICAL SCIENCES, 2019, 40 (06) : 1111 - 1124
  • [4] Myasthenia gravis and infectious disease
    Gilhus, Nils Erik
    Romi, Fredrik
    Hong, Yu
    Skeie, Geir Olve
    [J]. JOURNAL OF NEUROLOGY, 2018, 265 (06) : 1251 - 1258
  • [5] A standardized protocol for the perioperative management of myasthenia gravis patients. Experience with 110 patients
    Gritti, P.
    Sgarzi, M.
    Carrara, B.
    Lanterna, L. A.
    Novellino, L.
    Spinelli, L.
    Khotcholava, M.
    Poli, G.
    Lorini, F. L.
    Sonzogni, V.
    [J]. ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2012, 56 (01) : 66 - 75
  • [6] Myasthenia Gravis
    Indraratna, Praveen
    Matar, Walid
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (13)
  • [7] Fluoroquinolone-Associated Myasthenia Gravis Exacerbation Evaluation of Postmarketing Reports from the US FDA Adverse Event Reporting System and a Literature Review
    Jones, S. Christopher
    Sorbello, Alfred
    Boucher, Robert M.
    [J]. DRUG SAFETY, 2011, 34 (10) : 839 - 847
  • [8] Myasthenia gravis exacerbation or unmasking associated with telithromycin treatment
    Perrot, X.
    Bernard, N.
    Vial, C.
    Antoine, J. C.
    Laurent, H.
    Vial, T.
    Confavreux, C.
    Vukusic, S.
    [J]. NEUROLOGY, 2006, 67 (12) : 2256 - 2258
  • [9] Sonawalla A B, 1989, J Pak Med Assoc, V39, P18